U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C50H68N14O10
Molecular Weight 1025.1627
Optical Activity UNSPECIFIED
Defined Stereocenters 7 / 7
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of BREMELANOTIDE

SMILES

CCCC[C@H](NC(C)=O)C(=O)N[C@H]1CC(=O)NCCCC[C@H](NC(=O)[C@H](CC2=CNC3=CC=CC=C23)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CC4=CC=CC=C4)NC(=O)[C@H](CC5=CN=CN5)NC1=O)C(O)=O

InChI

InChIKey=FFHBJDQSGDNCIV-MFVUMRCOSA-N
InChI=1S/C50H68N14O10/c1-3-4-16-35(58-29(2)65)43(67)64-41-25-42(66)54-20-11-10-18-37(49(73)74)60-46(70)39(23-31-26-56-34-17-9-8-15-33(31)34)62-44(68)36(19-12-21-55-50(51)52)59-45(69)38(22-30-13-6-5-7-14-30)61-47(71)40(63-48(41)72)24-32-27-53-28-57-32/h5-9,13-15,17,26-28,35-41,56H,3-4,10-12,16,18-25H2,1-2H3,(H,53,57)(H,54,66)(H,58,65)(H,59,69)(H,60,70)(H,61,71)(H,62,68)(H,63,72)(H,64,67)(H,73,74)(H4,51,52,55)/t35-,36-,37-,38+,39-,40-,41-/m0/s1

HIDE SMILES / InChI

Molecular Formula C50H68N14O10
Molecular Weight 1025.1627
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 7 / 7
E/Z Centers 1
Optical Activity UNSPECIFIED

Approval Year

Substance Class Chemical
Created
by admin
on Fri Dec 15 16:28:06 UTC 2023
Edited
by admin
on Fri Dec 15 16:28:06 UTC 2023
Record UNII
6Y24O4F92S
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
BREMELANOTIDE
INN   USAN  
INN   USAN  
Official Name English
N-ACETYL-L-2-AMINOHEXANOYL-L-.ALPHA.-ASPARTYL-L-HISTIDYL-D-PHENYLALANYL-L-ARGINYL-L-TRYPTOPHYL-L-LYSINE-(2->7)-LACTAM
Common Name English
bremelanotide [INN]
Common Name English
L-LYSINE, N-ACETYL-L-NORLEUCYL-L-.ALPHA.-ASPARTYL-L-HISTIDYL-D-PHENYLALANYL-L-ARGINYL-L-TRYPTOPHYL-, (2->7)-LACTAM
Common Name English
PT-141 FREE BASE
Code English
Bremelanotide [WHO-DD]
Common Name English
BREMELANOTIDE [USAN]
Common Name English
BREMELANOTIDE [MI]
Common Name English
Classification Tree Code System Code
WIKIPEDIA Designer-drugs-Bremelanotide
Created by admin on Fri Dec 15 16:28:07 UTC 2023 , Edited by admin on Fri Dec 15 16:28:07 UTC 2023
NCI_THESAURUS C548
Created by admin on Fri Dec 15 16:28:07 UTC 2023 , Edited by admin on Fri Dec 15 16:28:07 UTC 2023
Code System Code Type Description
CAS
189691-06-3
Created by admin on Fri Dec 15 16:28:06 UTC 2023 , Edited by admin on Fri Dec 15 16:28:06 UTC 2023
PRIMARY
MERCK INDEX
m12151
Created by admin on Fri Dec 15 16:28:07 UTC 2023 , Edited by admin on Fri Dec 15 16:28:07 UTC 2023
PRIMARY
FDA UNII
6Y24O4F92S
Created by admin on Fri Dec 15 16:28:07 UTC 2023 , Edited by admin on Fri Dec 15 16:28:07 UTC 2023
PRIMARY
ChEMBL
CHEMBL2070241
Created by admin on Fri Dec 15 16:28:06 UTC 2023 , Edited by admin on Fri Dec 15 16:28:06 UTC 2023
PRIMARY
MESH
C476721
Created by admin on Fri Dec 15 16:28:07 UTC 2023 , Edited by admin on Fri Dec 15 16:28:07 UTC 2023
PRIMARY
DAILYMED
6Y24O4F92S
Created by admin on Fri Dec 15 16:28:06 UTC 2023 , Edited by admin on Fri Dec 15 16:28:06 UTC 2023
PRIMARY
NCI_THESAURUS
C77009
Created by admin on Fri Dec 15 16:28:07 UTC 2023 , Edited by admin on Fri Dec 15 16:28:07 UTC 2023
PRIMARY
PUBCHEM
9941379
Created by admin on Fri Dec 15 16:28:07 UTC 2023 , Edited by admin on Fri Dec 15 16:28:07 UTC 2023
PRIMARY
DRUG BANK
DB11653
Created by admin on Fri Dec 15 16:28:06 UTC 2023 , Edited by admin on Fri Dec 15 16:28:06 UTC 2023
PRIMARY
EPA CompTox
DTXSID40893711
Created by admin on Fri Dec 15 16:28:07 UTC 2023 , Edited by admin on Fri Dec 15 16:28:07 UTC 2023
PRIMARY
INN
8737
Created by admin on Fri Dec 15 16:28:07 UTC 2023 , Edited by admin on Fri Dec 15 16:28:07 UTC 2023
PRIMARY
WIKIPEDIA
BREMELANOTIDE
Created by admin on Fri Dec 15 16:28:07 UTC 2023 , Edited by admin on Fri Dec 15 16:28:07 UTC 2023
PRIMARY
RXCUI
2176312
Created by admin on Fri Dec 15 16:28:07 UTC 2023 , Edited by admin on Fri Dec 15 16:28:07 UTC 2023
PRIMARY
DRUG CENTRAL
5329
Created by admin on Fri Dec 15 16:28:07 UTC 2023 , Edited by admin on Fri Dec 15 16:28:07 UTC 2023
PRIMARY
USAN
RR-45
Created by admin on Fri Dec 15 16:28:07 UTC 2023 , Edited by admin on Fri Dec 15 16:28:07 UTC 2023
PRIMARY
LACTMED
Bremelanotide
Created by admin on Fri Dec 15 16:28:07 UTC 2023 , Edited by admin on Fri Dec 15 16:28:07 UTC 2023
PRIMARY
Related Record Type Details
TARGET -> AGONIST
BINDER->LIGAND
BINDING
PARENT -> DERIVATIVE
TARGET -> AGONIST
TARGET -> AGONIST
SALT/SOLVATE -> PARENT
TARGET -> AGONIST
TARGET -> AGONIST
Related Record Type Details
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Tmax PHARMACOKINETIC
Volume of Distribution PHARMACOKINETIC SINGLE SUBCUTANEOUS ADMINISTRATION

Biological Half-life PHARMACOKINETIC